Catheter Precision (VTAK) Stock Price, News & Analysis

Company Overview

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Key Stats

• Today's Range: $0.21 to $0.22
• 50-Day Range: $0.19 to $0.35
• 52-Week Range: $0.16 to $8.40
• Volume: 329,461 shs
• Average Volume: 1.17 million shs
• Market Capitalization: $1.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VTAK Stock Analysis - Frequently Asked Questions

How have VTAK shares performed this year?

Catheter Precision's stock was trading at $0.4491 at the beginning of the year. Since then, VTAK shares have decreased by 52.9% and is now trading at $0.2117.
View the best growth stocks for 2025 here.

When did Catheter Precision's stock split?

Shares of Catheter Precision reverse split on the morning of Monday, July 15th 2024. The 1-10 reverse split was announced on Monday, July 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Catheter Precision's major shareholders?

Top institutional shareholders of Catheter Precision include Armistice Capital LLC (2.84%) and Warberg Asset Management LLC (2.04%). Insiders that own company stock include David A Jenkins and Martin J Colombatto.
View institutional ownership trends.

How do I buy shares of Catheter Precision?

Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Catheter Precision own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB).

Company Calendar

• Today: 6/06/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSEAMERICAN:VTAK
• CIK: 1716621
• Web: www.catheterprecision.com
• Phone: 973-691-2000
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$70.57 million
• Net Margins: -2,928.32%
• Pretax Margin: -2,928.32%
• Return on Equity: -69.90%
• Return on Assets: -41.82%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 0.66
• Quick Ratio: 0.65

Sales & Book Value

• Annual Sales: $440,000.00
• Price / Sales: 4.12
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $30.16 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 8,840,000
• Free Float: 8,720,000
• Market Cap: $1.81 million
• Optionable: N/A
• Beta: -0.34